KAM
LJPC

Kazazian Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Kazazian Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18,076
Closed -$364K – 106
2018
Q3 		$364K Buy
18,076
+3,133
+21% +$81.9K 0.34% 53
2018
Q2 		$436K Sell
14,943
-573
-4% -$17.7K 0.4% 50
2018
Q1 		$462K Buy
15,516
+3,253
+27% +$105K 0.48% 48
2017
Q4 		$395K Buy
12,263
+1,271
+12% +$41.5K 0.4% 56
2017
Q3 		$382K Buy
+10,992
New +$353K 0.47% 48

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kazazian Asset Management's LJPC Position: Q4 2018 in Review

Kazazian Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2018, closing a stake of 18,076 shares — an estimated $364K sold.

Kazazian Asset Management first reported a position in LJPC in Q3 2017 and held it in 5 quarters. The position peaked at $462K in Q1 2018. 83 funds tracked by Wall St. Rank hold LJPC as of Q4 2018.

  • Kazazian Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2018 after selling out during the quarter.
  • Kazazian Asset Management sold 18,076 La Jolla Pharmaceutical Company shares in Q4 2018, an estimated $364K.
  • Kazazian Asset Management first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 5 quarters.
  • Kazazian Asset Management's La Jolla Pharmaceutical Company position peaked at $462K in Q1 2018.
  • 83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2018.

Based on Kazazian Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.